Archive - January 2022
Amgen’s Lumykras receives conditional marketing authorisation from EC
Pregnant women urged to receive COVID-19 booster amid surging cases
The NICE recommends Rinvoq for psoriatic arthritis patients
COVID Is Caused By A Virus — So Why Are Researchers Treating It With Antibiotics?
From Delta To Omicron, Here’s How Scientists Know Which Coronavirus Variants Are Circulating In The US
7 Best Running Shoes Of 2022
Sanofi and Exscientia agree on a deal worth up to $5.2bn for AI-driven therapies
NICE recommends MSD’s Keytruda in combination with chemotherapy for routine treatment of lung cancer